EUTM file information
018181806
MEDX
January 15, 2020
Trademark Summary
The trademark MEDX was filed by Noumed Life Sciences Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on February 6, 2020, and received four oppositions.
Opposition Proceedings
There are four oppositions were filed:
- The first opposition filed on May 17, 2020 by The Procter & Gamble Company on Likelihood of confusion. the opponent was represented by Brunner, Renate and its proceedings were handled in English
- The second opposition filed on May 3, 2020 by medac Gesellschaft für klinische Spezialpräparate mbH on Likelihood of confusion. the opponent was represented by UEXKÜLL & STOLBERG PARTNERSCHAFT VON PATENT- UND RECHTSANWÄLTEN MBB and its proceedings were handled in English
- The third opposition filed on April 20, 2020 by MedPalett AS on Likelihood of confusion. the opponent was represented by Weiß, Roland and its proceedings were handled in English
- The fourth opposition filed on March 23, 2020 by null on Likelihood of confusion. the opponent was represented by ELKINGTON AND FIFE LLP and its proceedings were handled in English
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Change of name and address of the trademark registration was recorded on March 4, 2020.
Goods And Services
- The mark was filed in class 5 with following description of goods:
- Vaccines
- Pharmaceutical cough preparations
- Dermatological pharmaceutical substances
- Pharmaceutical cold preparations
- Pharmaceuticals
- Dietary supplements for humans
- Chemical preparations for pharmaceutical purposes
- Pharmaceutical drugs
- Pharmaceuticals and natural remedies
- Pharmaceutical compositions
- Pharmaceutical preparations for human use
- Pharmaceutical creams
- Pharmaceutical preparations.
